Axitinib – Kidney Cancer Treatment

Axitinib is a targeted anticancer medication used in the treatment of kidney cancer (renal cell carcinoma) at advanced stages. Axitinib is a tyrosine kinase inhibitor that blocks the enzymes stimulating the growth of blood vessels necessary to supply nutrients to the tumor. This slows down the growth and spread of cancer cells in the body, helping to control disease progression and improve patients’ quality of life. Axitinib is often used after other lines of therapy.